User menu

Calcium Ions Promote Formation of Amyloid beta-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease

Bibliographic reference Itkin, Anna ; Dupres, Vincent ; Dufrêne, Yves ; Bechinger, Burkhard ; Ruysschaert, Jean-Marie ; et. al. Calcium Ions Promote Formation of Amyloid beta-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease. In: PLoS One, Vol. 6, no. 3, p. e18250 (2011)
Permanent URL http://hdl.handle.net/2078.1/75340
  1. Hardy J., Higgins G., Alzheimer's disease: the amyloid cascade hypothesis, 10.1126/science.1566067
  2. Cummings B.J, Cotman C.W, Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity, 10.1016/s0140-6736(95)92053-6
  3. Näslund Jan, Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline, 10.1001/jama.283.12.1571
  4. MC Irizarry, J Neurosci, 17, 7053 (1997)
  5. Tabira Takeshi, Chui De-Hua, Tanahashi Hiroshi, Ozawa Kazuharu, Ikeda Sachiya, Checler Frédéric, Ueda Otoya, Suzuki Hiroshi, Araki Wataru, Inoue Haruhisa, Shirotani Keiro, Takahashi Keikichi, Gallyas Ferenc, 10.1038/8438
  6. Klein W, Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?, 10.1016/s0166-2236(00)01749-5
  7. Hardy J., The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics, 10.1126/science.1072994
  8. Lue Lih-Fen, Kuo Yu-Min, Roher Alex E., Brachova Libuse, Shen Yong, Sue Lucia, Beach Thomas, Kurth Janice H., Rydel Russel E., Rogers Joseph, Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease, 10.1016/s0002-9440(10)65184-x
  9. Rowan M.J., Klyubin I., Wang Q., Hu N.W., Anwyl R., Synaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction: Figure 1, 10.1042/bst0351219
  10. McLean Catriona A., Cherny Robert A., Fraser Fiona W., Fuller Stephanie J., Smith Margaret J., Konrad Vbeyreuther, Bush Ashley I., Masters Colin L., Soluble pool of A? amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, 10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
  11. Bliss T. V. P., Lømo T., Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path, 10.1113/jphysiol.1973.sp010273
  12. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., Morgan T. E., Rozovsky I., Trommer B., Viola K. L., Wals P., Zhang C., Finch C. E., Krafft G. A., Klein W. L., Diffusible, nonfibrillar ligands derived from A 1-42 are potent central nervous system neurotoxins, 10.1073/pnas.95.11.6448
  13. Walsh Dominic M., Klyubin Igor, Fadeeva Julia V., Cullen William K., Anwyl Roger, Wolfe Michael S., Rowan Michael J., Selkoe Dennis J., Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, 10.1038/416535a
  14. Wang Hai-Wei, Pasternak Joseph F, Kuo Helen, Ristic Helen, Lambert Mary P, Chromy Brett, Viola Kirsten L, Klein William L, Stine W.Blaine, Krafft Grant A, Trommer Barbara L, Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus, 10.1016/s0006-8993(01)03058-x
  15. Selkoe Dennis J., The molecular pathology of Alzheimer's disease, 10.1016/0896-6273(91)90052-2
  16. DJ Selkoe, Physiol Rev, 81, 741 (2001)
  17. Bossy-Wetzel Ella, Schwarzenbacher Robert, Lipton Stuart A, Molecular pathways to neurodegeneration, 10.1038/nm1067
  18. Stine W. Blaine, Dahlgren Karie N., Krafft Grant A., LaDu Mary Jo, In VitroCharacterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis, 10.1074/jbc.m210207200
  19. Nilsberth Camilla, Westlind-Danielsson Anita, Eckman Christopher B., Condron Margaret M., Axelman Karin, Forsell Charlotte, Stenh Charlotte, Luthman Johan, Teplow David B., Younkin Steven G., Näslund Jan, Lannfelt Lars, The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation, 10.1038/nn0901-887
  20. Päiviö A, Jarvet J, Gräslund A, Lannfelt L, Westlind-Danielsson A, Unique Physicochemical Profile of β-Amyloid Peptide Variant Aβ1–40E22G Protofibrils: Conceivable Neuropathogen in Arctic Mutant Carriers, 10.1016/j.jmb.2004.03.028
  21. Whalen Brian M., Selkoe Dennis J., Hartley Dean M., Small non-fibrillar assemblies of amyloid β-protein bearing the Arctic mutation induce rapid neuritic degeneration, 10.1016/j.nbd.2005.03.007
  22. K Kamino, Am J Hum Genet, 51, 998 (1992)
  23. Mattson Mark P., addendum: Pathways towards and away from Alzheimer's disease, 10.1038/nature02940
  24. Smith Ian F., Green Kim N., LaFerla Frank M., Calcium dysregulation in Alzheimer's disease: Recent advances gained from genetically modified animals, 10.1016/j.ceca.2005.06.021
  25. Stutzmann Grace E., Calcium Dysregulation, IP3 Signaling, and Alzheimer’s Disease, 10.1177/1073858404270899
  26. KHACHATURIAN Z. S., Calcium Hypothesis of Alzheimer's Disease and Brain Aginga, 10.1111/j.1749-6632.1994.tb44398.x
  27. J Xiong, J Neurosci, 22, 10761 (2002)
  28. Bezprozvanny Ilya, Mattson Mark P., Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease, 10.1016/j.tins.2008.06.005
  29. Bojarski Lukasz, Herms Jochen, Kuznicki Jacek, Calcium dysregulation in Alzheimer's disease, 10.1016/j.neuint.2007.10.002
  30. Green Kim N., LaFerla Frank M., Linking Calcium to Aβ and Alzheimer's Disease, 10.1016/j.neuron.2008.07.013
  31. Etcheberrigaray René, Hirashima Naohide, Nee Linda, Prince José, Govoni Stefano, Racchi Marco, Tanzi Rudolph E., Alkon Daniel L., Calcium Responses in Fibroblasts from Asymptomatic Members of Alzheimer's Disease Families, 10.1006/nbdi.1998.0176
  32. Ito E., Oka K., Etcheberrigaray R., Nelson T. J., McPhie D. L., Tofel-Grehl B., Gibson G. E., Alkon D. L., Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease., 10.1073/pnas.91.2.534
  33. MP Mattson, J Neurosci, 12, 376 (1992)
  34. Kawahara Masahiro, Kuroda Yoichiro, Arispe Nelson, Rojas Eduardo, Alzheimer's β-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line, 10.1074/jbc.275.19.14077
  35. Mattson Mark P., Engle M. G., Rychlik B., Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons, 10.1007/bf03159951
  36. MP Mattson, Ann NY Acad Sci, 747, 50 (1994)
  37. Ferreiro Elisabete, Oliveira Catarina R., Pereira Cl�udia, Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid-? peptide, 10.1002/jnr.20135
  38. AC Paula-Lima, Antioxid Redox Signal, 14 (2011)
  39. Stutzmann Grace E., The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”?, 10.1177/1073858407299730
  40. De Felice Fernanda G., Velasco Pauline T., Lambert Mary P., Viola Kirsten, Fernandez Sara J., Ferreira Sergio T., Klein William L., Aβ Oligomers Induce Neuronal Oxidative Stress through anN-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine, 10.1074/jbc.m607483200
  41. Arispe N., Pollard H. B., Rojas E., Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes., 10.1073/pnas.90.22.10573
  42. Kagan B.L., Azimov R., Azimova R., Amyloid Peptide Channels, 10.1007/s00232-004-0709-4
  43. Querfurth Henry W., Selkoe Dennis J., Calcium Ionophore Increases Amyloid .beta. Peptide Production by Cultured Cells, 10.1021/bi00181a016
  44. Pierrot Nathalie, Santos Susana Ferrao, Feyt Christine, Morel Marina, Brion Jean-Pierre, Octave Jean-Noël, Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation, 10.1074/jbc.m606015200
  45. Naiki Hironobu, Higuchi Keiichi, Hosokawa Masanori, Takeda Toshio, Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T, 10.1016/0003-2697(89)90046-8
  46. Benseny-Cases Núria, Cócera Mercedes, Cladera Josep, Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer’s disease amyloid peptide aggregation, 10.1016/j.bbrc.2007.07.082
  47. Groenning Minna, Olsen Lars, van de Weert Marco, Flink James M., Frokjaer Sven, Jørgensen Flemming S., Study on the binding of Thioflavin T to β-sheet-rich and non-β-sheet cavities, 10.1016/j.jsb.2006.12.010
  48. Krebs M.R.H., Bromley E.H.C., Donald A.M., The binding of thioflavin-T to amyloid fibrils: localisation and implications, 10.1016/j.jsb.2004.08.002
  49. Lashuel Hilal A., Hartley Dean M., Petre Benjamin M., Wall Joseph S., Simon Martha N., Walz Thomas, Lansbury Peter T., Mixtures of Wild-type and a Pathogenic (E22G) Form of Aβ40 in Vitro Accumulate Protofibrils, Including Amyloid Pores, 10.1016/s0022-2836(03)00927-6
  50. Cerf Emilie, Sarroukh Rabia, Tamamizu-Kato Shiori, Breydo Leonid, Derclaye Sylvie, Dufrêne Yves F., Narayanaswami Vasanthy, Goormaghtigh Erik, Ruysschaert Jean-Marie, Raussens Vincent, Antiparallel β-sheet: a signature structure of the oligomeric amyloid β-peptide, 10.1042/bj20090379
  51. Chirgadze Yu. N., Nevskaya N. A., Infrared spectra and resonance interaction of amide-I vibration of the antiparallel-chain pleated sheet, 10.1002/bip.1976.360150402
  52. Goormaghtigh Erik, Cabiaux Véronique, Ruysschaert Jean-Marie, Determination of Soluble and Membrane Protein Structure by Fourier Transform Infrared Spectroscopy, Subcellular Biochemistry (1994) ISBN:9781461357575 p.329-362, 10.1007/978-1-4615-1863-1_8
  53. Dahlgren Karie N., Manelli Arlene M., Stine W. Blaine, Baker Lorinda K., Krafft Grant A., LaDu Mary Jo, Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability, 10.1074/jbc.m201750200
  54. Haass Christian, Selkoe Dennis J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide, 10.1038/nrm2101
  55. Mastrangelo Iris A., Ahmed Mahiuddin, Sato Takeshi, Liu Wei, Wang Chengpu, Hough Paul, Smith Steven O., High-resolution Atomic Force Microscopy of Soluble Aβ42 Oligomers, 10.1016/j.jmb.2006.01.042
  56. Lord Anna, Kalimo Hannu, Eckman Chris, Zhang Xiao-Qun, Lannfelt Lars, Nilsson Lars N.G., The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice, 10.1016/j.neurobiolaging.2004.12.007
  57. Isaacs Adrian M., Senn David B., Yuan Menglan, Shine James P., Yankner Bruce A., Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium, 10.1074/jbc.m602061200
  58. Ahmad Atta, Muzaffar Mahvish, Ingram Vernon M., Ca2+, within the physiological concentrations, selectively accelerates Aβ42 fibril formation and not Aβ40 in vitro, 10.1016/j.bbapap.2009.06.022
  59. KURODA YOICHIRO, KAWAHARA MASAHIRO, Aggregation of Amyloid .BETA.-Protein and Its Neurotoxicity: Enhancement by Aluminum and Other Metals., 10.1620/tjem.174.263
  60. Budd Samantha L., Nicholls David G., Mitochondria in the life and death of neurons, 10.1042/bse0330043
  61. LaFerla Frank M., Calcium dyshomeostasis and intracellular signalling in alzheimer's disease, 10.1038/nrn960
  62. EC Toescu, Altered Calcium Homeostasis in Old Neurons (2007)
  63. LaFerla Frank M., Green Kim N., Oddo Salvatore, Intracellular amyloid-β in Alzheimer's disease, 10.1038/nrn2168
  64. Arispe N., Rojas E., Pollard H. B., Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum., 10.1073/pnas.90.2.567
  65. Bucciantini Monica, Calloni Giulia, Chiti Fabrizio, Formigli Lucia, Nosi Daniele, Dobson Christopher M., Stefani Massimo, Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity, 10.1074/jbc.m400348200
  66. Rovira Catherine, Arbez Nicolas, Mariani Jean, Aβ(25–35) and Aβ(1–40) act on different calcium channels in CA1 hippocampal neurons, 10.1016/s0006-291x(02)02072-7
  67. Dewachter I., Filipkowski R.K., Priller C., Ris L., Neyton J., Croes S., Terwel D., Gysemans M., Devijver H., Borghgraef P., Godaux E., Kaczmarek L., Herms J., Van Leuven F., Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice, 10.1016/j.neurobiolaging.2007.06.011
  68. Molnár Zsolt, Soós Katalin, Lengyel Imre, Penke Botond, Szegedi Viktor, Budai Dénes, Enhancement of NMDA responses by β-amyloid peptides in the hippocampus in vivo : , 10.1097/01.wnr.0000134471.06244.d2
  69. Shankar G. M., Bloodgood B. L., Townsend M., Walsh D. M., Selkoe D. J., Sabatini B. L., Natural Oligomers of the Alzheimer Amyloid-  Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway, 10.1523/jneurosci.4970-06.2007
  70. Li Shaomin, Hong Soyon, Shepardson Nina E., Walsh Dominic M., Shankar Ganesh M., Selkoe Dennis, Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake, 10.1016/j.neuron.2009.05.012